Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-02-28
2006-02-28
Richter, Johann (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S238000
Reexamination Certificate
active
07005432
ABSTRACT:
The present invention relates to compounds of formulawherein A is an unsubstituted or substituted cyclic group; andR is hydrogen or lower alkyl;or a pharmaceutically acceptable acid addition salt thereof.These compounds are NMDA NR-2B receptor subtype specific blockers and are useful in the treatment of neurodegeneration, depression and pain.
REFERENCES:
patent: 5962472 (1999-10-01), Bourson et al.
patent: 6265426 (2001-07-01), Alanine et al.
patent: 6310213 (2001-10-01), Alanine et al.
patent: 6339093 (2002-01-01), Alanine et al.
patent: 6359138 (2002-03-01), Alanine et al.
patent: 2001/0047014 (2001-11-01), Alanine et al.
patent: 2001/0047031 (2001-11-01), Alanine et al.
patent: 0 937 458 (1999-08-01), None
patent: 1 254 661 (2002-04-01), None
patent: WO 02/28814 (2002-04-01), None
patent: WO 02/085352 (2002-10-01), None
patent: 03/097637 (2003-11-01), None
Robert McBurney, Therapeutic Potential of NMDA Antagonists in Neurodegenerative Diseases, Nuerobiology of Aging, vol. 15, No. 2, pp. 271-273 (1994).
Ikonomidou et al., Neurodegenerative Disorders: Clues from Glutamate and Energy Metabolism, Critical Reviews in Neurobiology, 10(2), pp. 239-263 (1996).
Bryant et al.,J. Heterocycl. Chem., vol. 32(5), pp. 1473-1476 (1995).
M. Adamczyk et al.,J. Org. Chem., vol. 49, pp. 4226-4237 (1984).
J. S. Sawyer et al.,J. Am. Chem. Soc., vol. 110, pp. 842-853 (1988).
Buettelmann Bernd
Heitz Neidhart Marie-Paule
Jaeschke Georg
Pinard Emmanuel
Hoffman-La Roche Inc.
Johnston George W.
Prior Kimberly J.
Richter Johann
Rocha-Tramaloni Patricia S.
LandOfFree
Substituted imidazol-pyridazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazol-pyridazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazol-pyridazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3651298